There is a growing number of individuals who do not fully recover after COVID. They don’t go back to previous levels of health and function following an acute infection by coronavirus (COVID), but rather develop so-called "Post-COVID" Syndrome. This page shares information about appliance of Naltrexone for Post-COVID Syndrome treatment.
Firstly, it is important o emphasis that long-COVID or Post-COVID syndrome is multi-causal. It has a significant proportion of Long-COVID cases developing a clinical picture that is very similar to chronic fatigue syndrome. Post-viral fatigue syndrome, too.
We will refer to this new illness as post-COVID-19 fatigue syndrome (PCFS). It is characterized by:
- persistent disabling fatigue
- nonrestorative sleep
- post-exertional malaise.
PE malaise is the worsening of symptoms following even minor physical or mental exertion. Symptoms typically worsen 12 to 48 hours after activity and lasting for days or even weeks
Diagnosis is clinical and based on symptom reports. Viral and other infections are 25 times more likely to trigger prolonged fatigue syndrome than any other factor.
This highlights the possibility of ex-COVID-19 patients having post-viral symptoms which progress to PCFS, either as the only sequelae or combined with other dysfunctions. Other Long-COVID symptoms in addition to PCFS include:
- a) post-intensive care syndrome;
- b) organ damage
- c) other debilitating symptoms related to mental health and other conditions.
Naltrexone for Post-COVID Syndrome
The impact of the COVID-19 pandemic is huge. That makes finding evidence for an effective and safe treatment for PCFS urgent. As currently there is no curative treatment Post Covid Fatigue Syndrome, the prognosis for many post covid survivors seem to be bleak.
A huge number of people are predicted to be impacted by the long-term morbidity and disability associated with these conditions. This means high costs to healthcare and social services.
Naltrexone for Post-COVID Syndrome is becoming an efficient treatment option.
Scientific research and trials have proven that Naltrexone for post-covid syndrome has been proven to be helpful in the treatment of PCFS. It is provided as a compounded capsule starting at a strength of 1mg/day of naltrexone and increasing up to a maximum of 4.5 mg/day.
In addition to all mentioned above, Naltrexone has been proven to be effective in the treatment of Post Covid Fatigue Syndrome followed by a deficit of cognitive functions.
Is Naltrexone for Post-COVID Syndrome really working?
Dr. Jack Lambert, a university professor from Dublin - Ireland had been prescribing a low dose of Naltrexone for relieving pain and fatigue related to Liam's disease.
Furthermore, he has recommended to his colleagues prescribing Naltrexone who suffer from Long Covid Fatigue Syndrome.
A successful study had been completed involving 38 patients. They reported experiencing an energy increase after taking Naltrexone. Other improvements were pain relief and better sleep, too. Their general health became improved after 2 months was Naltrexone intake.
Naltrexone is effective in the treatment of some inflammations. Because of that, Medical Doctors have been using it for years in the treatment of some conditions like fibromyalgia. This is a rheumatic illness characterized by muscle and joint pain, Crone's disease (inflammation of the digestive tract), and multiple sclerosis.
Dr. Lambert believes that low-dose Naltrexone can not only mask the symptoms, but lead to significant improvement in the health of post Covid sufferers. Clinical trials.